Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1983 Jun;17(6):988–992. doi: 10.1128/jcm.17.6.988-992.1983

Demonstration of intraocular synthesis of immunoglobulin G toxoplasma antibodies for specific diagnosis of toxoplasmic chorioretinitis by enzyme immunoassay.

H J Turunen, P O Leinikki, K M Saari
PMCID: PMC272788  PMID: 6348082

Abstract

By using a modified enzyme immunoassay we have conducted a detailed study on the intraocular synthesis of toxoplasma antibodies during ocular toxoplasmosis. In control patients operated on for cataracts, the ratio of immunoglobulin G (IgG) toxoplasma antibodies in serum to those in aqueous humor was more than 100. In eight of the nine patients with clinically diagnosed toxoplasmic chorioretinitis, the ratio ranged between 6 and 56. In five patients with some other type of uveitis, the ratio was comparable with that in controls. Parallel determinations of mumps IgG antibody ratios were carried out to prove that the increased intraocular toxoplasma antibody levels were not a result of increased diffusion or polyclonal antibody stimulation. In all patients, mumps antibody ratios were within normal range. We also tested the samples of aqueous humor for IgM and IgA antibodies, but the antibodies in the aqueous humor were found to be exclusively IgG. Our results indicate that IgG-class anti-toxoplasma antibodies are produced locally within the eye in cases of toxoplasmic chorioretinitis. The determination of these antibodies can offer a valuable aid to make a specific etiological diagnosis of ocular toxoplasmosis.

Full text

PDF
988

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Desmonts G., Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med. 1974 May 16;290(20):1110–1116. doi: 10.1056/NEJM197405162902003. [DOI] [PubMed] [Google Scholar]
  2. Desmonts G. Definitive serological diagnosis of ocular toxoplasmosis. Arch Ophthalmol. 1966 Dec;76(6):839–851. doi: 10.1001/archopht.1966.03850010841012. [DOI] [PubMed] [Google Scholar]
  3. Leinikki P., Shekarchi I., Iivanainen M., Taskinen E., Holmes K. V., Madden D., Sever J. L. Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests. J Neurol Sci. 1982 Dec;57(2-3):249–255. doi: 10.1016/0022-510X(82)90031-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. O'Connor G. R. Manifestations and management of ocular toxoplasmosis. Bull N Y Acad Med. 1974 Feb;50(2):192–210. [PMC free article] [PubMed] [Google Scholar]
  5. Remington J. S. Toxoplasmosis in the adult. Bull N Y Acad Med. 1974 Feb;50(2):211–227. [PMC free article] [PubMed] [Google Scholar]
  6. Remky H. Vergleichende Untersuchungen von Kammerwasser und Serum mittels des Dye-Tests. Klin Monbl Augenheilkd. 1968;153(5):617–623. [PubMed] [Google Scholar]
  7. Saari M. Toxoplasmic chorioretinitis affecting the macula. Acta Ophthalmol (Copenh) 1977 Jun;55(3):539–547. doi: 10.1111/j.1755-3768.1977.tb06132.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES